John Gever
MedPage Today
Pittsburgh, PA, United States
Contact John
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by John:
Does Sunlight Trigger Lupus?
Analysis of data from major study suggests 'yes,' but falls short of clear conclusion → Read More
Study: Some COVID Survivors 'Sicker Than They Feel'
Performance on 6-minute walk doesn't match self-reports of improved health → Read More
Uneven Responses to Extra COVID Vax Doses in Autoimmune Patients
Don't count on getting a substantial SARS-CoV-2 antibody boost from additional COVID-19 vaccine doses beyond the recommended boosters in patients with autoimmune diseases. Sixteen of a group of 18 such patients showed no effective anti-spike protein antibodies a median of 84 days after completing the initial two-dose series of the Pfizer-BioNTech and Moderna vaccines, or the single dose of the… → Read More
Progress on Allergies Highlighted at ACAAI
NEW ORLEANS -- As the American College of Allergy, Asthma, & Immunology (ACAAI) annual meeting gets underway on Friday, attendees -- online and in person here -- can catch up on the latest news on allergy prevention and management, as well as the gamut of topics summed up in the organization's name. Some of the highlight presentations include the following: * Eggs introduced in infancy may… → Read More
SOARS-B Trial Disappoints in Autism
Is this the end for a popular off-label therapy? → Read More
Preterm Birth, Autism Link Cemented
Big Swedish study documents 'dose-response' relationship → Read More
Does TikTok Push Vaping?
You'd have to look hard to find negative portrayals of e-cigarettes on popular video platform → Read More
FDA Breaks New Ground With Transplant Drug Approval
Tacrolimus (Prograf) won FDA approval late Friday to prevent lung transplant rejection, a newsworthy development on two counts. In addition to the immunosuppressant becoming the first to be OK'd for that indication, the decision is also the most tangible demonstration so far of the agency's new openness to "real-world evidence" as the basis for drug approvals. No prospective trial was conducted… → Read More
'Breakthrough' COVID Infections Less Transmissible, English Data Indicate
People who develop so-called breakthrough infections after receiving either the Pfizer-BioNTech or AstraZeneca vaccines were about half as likely to transmit the virus to household members, compared with households in which unvaccinated people brought the virus home, British researchers reported. Ross J. Harris, PhD, of Public Health England in London, and colleagues counted some 960,000… → Read More
Birthdays: Cake, Ice Cream ... and Increased COVID Risk?
Study makes a link, but public health implications hard to see → Read More
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment
Endoscopic procedure could yield benefits now seen only with more invasive surgery → Read More
Drug Prices: We've Seen This Movie Before
As happened with cars in the 1960s, price competition among brand-name drugs is hard to find → Read More
FDA: Xofluza OK for Preventing Infection
Baloxavir marboxil (Xofluza) can be used to prevent influenza illness in patients 12 and older who have been in close contact with an infected individual, the FDA said Monday. The drug thus joins oseltamivir (Tamiflu) in gaining a post-exposure prophylaxis indication, though the latter's is broader in that the FDA approved its use in children as young as 1. Baloxavir has a unique mechanism of… → Read More
Ethics Consult: Force Woman to Have Baby-Saving C-Section?
Welcome to Ethics Consult -- an opportunity to discuss, debate (respectfully), and learn together. We present an ethical dilemma in patient care (hypothetical for this edition); you vote on your decision in the case. Next week, we'll reveal how you all made the call. And stay tuned -- an ethics expert will weigh in next week with an ethical framework to help you learn and prepare. You are an… → Read More
New Type of COVID-19 Test OK'd
Quidel diagnostic gives quick results but it's less than perfect → Read More
Track the U.S. COVID-19 Outbreak in Real Time
Where and how many coronavirus cases diagnosed in this country → Read More
COVID-19 Update: 'It Will Go Away'; Insurers Promise Free Tests; Cancel Culture Grows
A daily roundup of news on the novel coronavirus outbreak → Read More
COVID-19: What's Cancelled, What Isn't
A handy list of medical meetings and whether you'll be able to attend → Read More
FDA Bans 'Aversive' Shock Treatment
Move comes 6 years after advisory panel urged end to controversial therapy → Read More
CDC Study: Lung Cancer Screening Rates Still Dismal
It would be an understatement to say that uptake of low-dose CT screening for lung cancer has been suboptimal, federal survey data indicated. Among individuals for whom screening is recommended, just 12.5% said they actually received it in the past 12 months, according to a CDC analysis of Behavioral Risk Factor Surveillance System (BRFSS) data from 10 geographically diverse states in 2017.… → Read More